Author:
Yao Yi,Yang Yanhui,Hu Qiuxia,Xie Xiaoyang,Jiang Wenjian,Liu Caiyang,Li Xiaoliang,Wang Yi,Luo Lei,Li Ji
Abstract
Abstract
Background
Currently, the differentiation between benign and malignant cystic pulmonary nodules poses a significant challenge for clinicians. The objective of this retrospective study was to construct a predictive model for determining the likelihood of malignancy in patients with cystic pulmonary nodules.
Methods
The current study involved 129 patients diagnosed with cystic pulmonary nodules between January 2017 and June 2023 at the Neijiang First People’s Hospital. The study gathered the clinical data, preoperative imaging features of chest CT, and postoperative histopathological results for both cohorts. Univariate and multivariate logistic regression analyses were employed to identify independent risk factors, from which a prediction model and nomogram were developed. In addition, The model's performance was assessed through receiver operating characteristic (ROC) curve analysis, calibration curve analysis, and decision curve analysis (DCA).
Results
A cohort of 129 patients presenting with cystic pulmonary nodules, consisting of 92 malignant and 37 benign lesions, was examined. Logistic data analysis identified a cystic airspace with a mural nodule, spiculation, mural morphology, and the number of cystic cavities as significant independent predictors for discriminating between benign and malignant cystic lung nodules. The nomogram prediction model demonstrated a high level of predictive accuracy, as evidenced by an area under the ROC curve (AUC) of 0.874 (95% CI: 0.804–0.944). Furthermore, the calibration curve of the model displayed satisfactory calibration. DCA proved that the prediction model was useful for clinical application.
Conclusion
In summary, the risk prediction model for benign and malignant cystic pulmonary nodules has the potential to assist clinicians in the diagnosis of such nodules and enhance clinical decision-making processes.
Funder
Technology Support Project of Neijiang City, Sichuan Province
Natural Science Foundation of Sichuan Province
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
2. Guo JT, Liang CY, Chu XY, et al. Thin-wall cavitary lung cancer: analysis of 24 cases and literature review. Zhongguo Fei Ai Za Zhi. 2014;17(7):553–6.
3. Womack NA, Graham EA. Epithelial metaplasia in congenital cystic disease of the lung: its possible relation to carcinoma of the bronchus. Am J Pathol. 1941;17(5):645–54.
4. Farooqi AO, Cham M, Zhang L, et al. Lung cancer associated with cystic airspaces. AJR Am J Roentgenol. 2012;199(4):781–6.
5. De Koning HJ, Dan der Aalst CM, De Jong PA, et al. Reduced lung-cancer mortality with volume Ct screening in a randomized trial. N Engl J Med. 2020;382(6):503–13.